These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Structural Consequences of Antigenic Variants of Human A/H3N2 Influenza Viruses. Burke DF. Viruses; 2023 Apr 19; 15(4):. PubMed ID: 37112987 [Abstract] [Full Text] [Related]
24. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. Abe Y, Takashita E, Sugawara K, Matsuzaki Y, Muraki Y, Hongo S. J Virol; 2004 Sep 19; 78(18):9605-11. PubMed ID: 15331693 [Abstract] [Full Text] [Related]
25. Using sequence data to infer the antigenicity of influenza virus. Sun H, Yang J, Zhang T, Long LP, Jia K, Yang G, Webby RJ, Wan XF. mBio; 2013 Jul 02; 4(4):. PubMed ID: 23820391 [Abstract] [Full Text] [Related]
26. A Deep Learning Approach for Predicting Antigenic Variation of Influenza A H3N2. Xia YL, Li W, Li Y, Ji XL, Fu YX, Liu SQ. Comput Math Methods Med; 2021 Jul 02; 2021():9997669. PubMed ID: 34697557 [Abstract] [Full Text] [Related]
28. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Smith DJ. Science; 2013 Nov 22; 342(6161):976-9. PubMed ID: 24264991 [Abstract] [Full Text] [Related]
29. [Traceability of the A/H3N2 virus borne influenza pandemic in Zhejiang province, 1998]. Feng Y, Xu CP, Huang W, Zhong SL, Yan JY, Mo SH, Lu YY. Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Feb 22; 31(2):204-7. PubMed ID: 21215085 [Abstract] [Full Text] [Related]
32. Reactivity of human convalescent sera with influenza virus hemagglutinin protein mutants at antigenic site A. Nobusawa E, Omagari K, Nakajima S, Nakajima K. Microbiol Immunol; 2012 Feb 22; 56(2):99-106. PubMed ID: 22309642 [Abstract] [Full Text] [Related]
33. Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. Huang JW, King CC, Yang JM. BMC Bioinformatics; 2009 Jan 30; 10 Suppl 1(Suppl 1):S41. PubMed ID: 19208143 [Abstract] [Full Text] [Related]
34. Primary structure of the gene coding for the haemagglutinin of influenza virus A/Leningrad/385/80(H3N2): detection of a point mutation responsible for the antigenic drift. Migunova BV, Plusnin AZ, Petrov NA, Rivkin MI, Grinbaum EB, Obuchova LV, Kuznetzov OK. Acta Virol; 1990 May 30; 34(3):209-19. PubMed ID: 1980394 [Abstract] [Full Text] [Related]
35. Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin. Kobayashi Y, Suzuki Y. J Virol; 2012 Apr 30; 86(7):3446-51. PubMed ID: 22258255 [Abstract] [Full Text] [Related]
36. Software for Characterizing the Antigenic and Genetic Evolution of Human Influenza Viruses. Reimering S, McHardy AC. Methods Mol Biol; 2018 Apr 30; 1836():551-565. PubMed ID: 30151591 [Abstract] [Full Text] [Related]
37. [Comparison of characterization of hemagglutination and HA1 sequence of currently circulating strains of influenza A (H3N2) virus in Zhejiang province and in Japan]. Lu YY, Yan JY, Zhou M, Jiang XL. Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jan 30; 24(1):15-8. PubMed ID: 12678955 [Abstract] [Full Text] [Related]
38. Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays. Huang JW, Lin WF, Yang JM. Vaccine; 2012 Sep 28; 30(44):6327-37. PubMed ID: 22885274 [Abstract] [Full Text] [Related]